Back to STATE STREET CORP STATE STREET CORP

LXEOLXEO
Showing 8 of 10 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in LEXEO THERAPEUTICS INC

STATE STREET CORP holds 4.4M shares of LXEO (LEXEO THERAPEUTICS INC), worth $20.3M as of 2026-Q2. The position was increased (+22.0% shares). LXEO represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$20.3M

Current Shares

4.4M

Total Value Change

+$18M

Total Shares Change

+4.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.4M
+22.0%
$20.3M0.0%$4.66
34
2026-Q1
Increased
3.6M
+11.9%
$20.5M0.0%$7.07
32
2025-Q4
Increased
3.2M
+485.1%
$31.7M0.0%$9.74
47
2025-Q3
Increased
544,845
+6.2%
$3.6M0.0%$6.66
28
2025-Q2
Increased
513,026
+9.2%
$2.1M0.0%$4.12
28
2025-Q1
Increased
469,728
+2.7%
$1.6M0.0%$4.10
26
2024-Q4
Increased
457,403
+80.1%
$3M0.0%$6.54
40
2024-Q3
Increased
253,946
+29.4%
$2.3M0.0%$9.11
33

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used